ヘルスケア予測分析の市場規模、シェア、動向分析レポート：用途別、最終用途別、地域別、セグメント予測、2024年～2030年

ヘルスケア予測分析市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のヘルスケア予測分析市場規模は、2024年から2030年にかけて24.0％のCAGRを記録し、2030年までに672億6,000万米ドルに達する見込みです。

慢性疾患の世界の負担増とヘルスケア費用の増加は、ヘルスケア予測分析市場を牽引する主な要因であり、その結果、世界中で同分析の採用率が拡大しています。遠隔医療やその他の診察方法の採用が増加する中、EHRの採用により過去数年間で膨大な患者データが蓄積されるようになった。これはヘルスケアIT企業にとって、リスク管理、疾病管理、疾病の広がりと軌跡の理解、そして患者に適切な医療を提供し最良の結果をもたらすための予測分析に活用できます。

これらすべての要因が世界市場の成長を促進しています。また、慢性疾患の増加に伴う先進国や新興諸国のヘルスケア支出の増加も、市場の成長を後押しします。欧州地域では、2019年のGDPに占めるヘルスケア支出の割合は9.92%でした。技術の進歩だけでなく、遠隔診察やEHRなどによるCOVID-19パンデミックの間により、患者データの急速な生成により、データを分析し、より良い患者の転帰を指向する有意義な結果を導き出すことが可能になった。ヘルスケア予測分析ツールは、コストを削減し、医療提供者が最善の治療計画を決定するのを支援するだけでなく、保険会社からお金を回収するために行われる不正請求のリスクを大幅に削減します。

毎年、米国では数兆ドル相当の虚偽の保険金請求が行われています。医療提供者にとって、予測分析は大幅なコスト削減の鍵となっています。上記の要因は市場の成長に大きく寄与しています。予測アナリティクスの金融分野への応用は、日々の業務にこれらの予測ツールを導入することで節約できる膨大な金額により、このセグメントで最大となっています。不正行為が発見されれば、それだけで回避することができ、何兆ドルもの節約につながります。さらに、不必要な検査や投薬は、予測分析の助けを借りて回避することができ、最適な治療計画やエビデンスに基づく医療、または病気の治療のための個別化された薬を決定するのに役立ちます。

ある臨床試験では、オピオイド誘発性呼吸抑制患者における継続的モニタリングの経済的な意味について調査され、中央値の病院では年間最大53万5,531米ドルを節約でき、累積入院日数を103日短縮できることがわかった。支払者は、虚偽の請求に関連するリスクや、プロバイダーにとって懸念事項である高額な治療費を評価する保険会社で構成され、最終用途セグメントの大半のシェアを占めていました。保険金請求における不正を検出することによるコスト削減や経費節減のための予測分析ツールの採用は、このセグメントの成長を促進する主な要因です。医療提供者は、治療費の削減と、民間および政府系医療提供者の両方における幅広い採用率により、最も急成長しているカテゴリーです。

ヘルスケア予測分析市場レポートハイライト

• 2023年には金融アプリケーション分野が市場を独占し、35.5%の最大収益シェアを占める。
• ポピュレーションヘルス管理分野は、2024年から2030年にかけて最も速いCAGR 24.4%で成長すると予測されます。
• 2023年にはヘルスケアプロバイダー分野が最大の市場シェアを占めました。予測分析は、病院の管理プロセスを自動化し、人員配置の必要性を予測し、病院の薬剤費と供給コストを管理し、病院や他の医療提供者の業績を活用することができます。
• 支払者セグメントは予測期間中に大きく成長する見込みです。医療費の高騰は、医療の質を維持しながら財務リスクを管理する医療計画への圧力を高めています。
• 北米のヘルスケア予測分析市場は、2023年に48.4％の最大の売上シェアを占めました。個別化医療への需要の高まり、患者ケアの改善への注目の高まり、強固なヘルスケアインフラが市場成長を促進する要因となっています。
• アジア太平洋のヘルスケア予測分析市場は、可処分所得の増加、医療支出の増加、ヘルスケアにおける人工知能の統合などの技術進歩により、2024年から2030年にかけて最も速いCAGR 26.9％で成長すると予測されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヘルスケア予測分析市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• ヘルスケア予測分析市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 規制の枠組み
  • 新興技術の動向
  • ケーススタディと洞察
  • COVID-19の影響分析

第4章 ヘルスケア予測分析市場：用途の推定・動向分析

• セグメントダッシュボード
• 世界のヘルスケア予測分析市場：用途変動分析
• 世界のヘルスケア予測分析市場規模と動向分析、用途別、2018～2030年
• オペレーション管理
  • 需要予測
  • 人材計画とスケジュール
  • 入院患者のスケジュール
  • 外来診療スケジュール
• 財務
  • 収益サイクル管理
  • 不正行為検出
  • その他の財務用途
• 集団健康
  • 集団リスク管理
  • 患者エンゲージメント
  • 集団療法管理
  • その他の用途
• 臨床
  • 品質ベンチマーク
  • 患者ケアの強化
  • 臨床結果の分析と管理

第5章 ヘルスケア予測分析市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 世界ヘルスケア予測分析市場の最終用途変動分析
• 世界のヘルスケア予測分析市場規模と動向分析、最終用途別、2018～2030年
• 支払者
• プロバイダー
• ライフサイエンス産業

第6章 ヘルスケア予測分析市場：地域の推定・動向分析

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル
  • IBM
  • Verisk Analytics, Inc.
  • McKesson Corp.
  • SAS
  • Oracle
  • Allscripts（now Veradigm）
  • Optum, Inc.
  • MedeAnalytics, Inc.
  • INFRAGISTICS
  • Cloudera
  • Health Catalyst
  • IQVIA Inc
  • Inovalon
  • OSP

List of Tables

• Table 1 List of abbreviation
• Table 2 Global healthcare predictive analytics market, by region, 2018 - 2030 (USD Million)
• Table 3 Global healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 4 Global healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 5 North America healthcare predictive analytics market, by country, 2018 - 2030 (USD Million)
• Table 6 North America healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 7 North America healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 8 U.S. healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 9 U.S. healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 10 Canada healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 11 Canada healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 12 Mexico healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 13 Mexico healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 14 Europe healthcare predictive analytics market, by country, 2018 - 2030 (USD Million)
• Table 15 Europe healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 16 Europe healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 17 UK healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 18 UK healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 19 Germany healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 20 Germany healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 21 France healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 22 France healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 23 Italy healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 24 Italy healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 25 Spain healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 26 Spain healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 27 Denmark healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 28 Denmark healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 29 Sweden healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 30 Sweden healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 31 Norway healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 32 Norway healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 33 Asia Pacific healthcare predictive analytics market, by country, 2018 - 2030 (USD Million)
• Table 34 Asia Pacific healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 35 Asia Pacific healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 36 China healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 37 China healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 38 Japan healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 39 Japan healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 40 India healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 41 India healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 42 South Korea healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 43 South Korea healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 44 Australia healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 45 Australia healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 46 Thailand healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 47 Thailand healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 48 Latin America healthcare predictive analytics market, by country, 2018 - 2030 (USD Million)
• Table 49 Latin America healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 50 Latin America healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 51 Brazil healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 52 Brazil healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 53 Argentina healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 54 Argentina healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 55 MEA healthcare predictive analytics market, by country, 2018 - 2030 (USD Million)
• Table 56 MEA healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 57 MEA healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 58 South Africa healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 59 South Africa healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 60 Saudi Arabia healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 61 Saudi Arabia healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 62 UAE healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 63 UAE healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)
• Table 64 Kuwait healthcare predictive analytics market, by application, 2018 - 2030 (USD Million)
• Table 65 Kuwait healthcare predictive analytics market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Healthcare Predictive Analytics market: Market outlook
• Fig. 5 Healthcare Predictive Analytics market: Segment outlook
• Fig. 6 Healthcare Predictive Analytics market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Healthcare predictive analytics market driver impact
• Fig. 9 Healthcare predictive analytics market restraint impact
• Fig. 10 Healthcare predictive analytics market: Application outlook and key takeaways
• Fig. 11 Healthcare predictive analytics market: Application movement analysis
• Fig. 12 Operations management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Demand forecasting market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Workforce planning and scheduling market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Inpatient scheduling market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Outpatient scheduling market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Financial market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Revenue cycle management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Fraud detection market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Other financial applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Population health market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Population risk management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Patient engagement market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Population therapy management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Quality benchmarking market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Patient care enhancement market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Clinical outcome analysis and management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Healthcare predictive analytics market: End use outlook and key takeaways
• Fig. 31 Healthcare predictive analytics market: End use movement analysis
• Fig. 32 Payers market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 33 Providers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Life science industry market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 35 Global healthcare predictive analytics market: Regional outlook and key takeaways
• Fig. 36 Global healthcare predictive analytics market: Regional movement analysis
• Fig. 37 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Key country dynamics
• Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Key country dynamics
• Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Key country dynamics
• Fig. 43 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Key country dynamics
• Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Healthcare Predictive Analytics Market Growth & Trends:

The global healthcare predictive analytics market size is expected to reach USD 67.26 billion by 2030, registering a CAGR of 24.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising burden of chronic diseases on a global level coupled with the increasing cost of healthcare are the key factors driving the market for healthcare predictive analytics and is resulting in wider adoption rates of the same across the globe. With the increasing adoption of telehealth and other consultation methods, the adoption of EHRs has led to enormous patient data in the past few years. This can be leveraged by the healthcare IT companies for predictive analytics for risk management, disease management, understanding of disease spread & trajectory as well as in delivering proper medical care to the patient for the best outcomes.

All of these factors have been driving the global market growth. An increase in healthcare expenditure in developed and developing countries due to a rise in the number of chronic diseases will also support market growth. In the Europe region, the healthcare expenditure as a percentage of GDP in 2019 was 9.92%. Technological advancements as well as rapid generation of patient data, more so during the COVID-19 pandemic due to teleconsultations, EHRs, etc. have made it possible to analyze data and derive meaningful results, which are oriented towards better patient outcomes. The healthcare predictive analytics tools not only help reduce costs & assist the care providers to decide on the best treatment plans but also significantly reduce the risk of fraudulent claims made to recover money from insurance companies.

Annually, trillions of U.S. dollars' worth of false insurance claims are made. For providers, predictive analytics has been a key to reducing costs significantly. The above-mentioned factors contribute significantly to the growth of the market. The financial application of predictive analytics is the largest in the segment owing to the massive amounts of money that can be saved by deploying these predictive tools in day-to-day work. The frauds alone when detected can be averted and result in trillions of dollars saved, moreover unnecessary tests and medication can be avoided with the help of predictive analytics, which can help determine the best treatment plans and evidence-based medicine or personalized medicines for the treatment of the disease.

A trial conducted studied the financial implications of continuous monitoring in patients with opioid-induced respiratory depression, the study found that a median hospital could save up to $535,531 annually, and can shorten the cumulative stay by 103 days. The payers had the majority share of the end-use segment, comprising insurance companies who assess risk related to false claims as well as the high cost of treatments that are a concern for the providers. Adoption of predictive analytics tools for cost reduction as well as for saving money by detecting frauds in insurance claims is a major factor driving the growth of the segment. The providers are the fastest-growing category owing to the reduction in the cost of treatments and wider adoption rates among both private as well as government-affiliated providers.

Healthcare Predictive Analytics Market Report Highlights:

• Financial application segment dominated the market in 2023 and accounted for the largest revenue share of 35.5%.
• Population health management segment is expected to grow at the fastest CAGR of 24.4% from 2024 to 2030.
• The healthcare providers segment held the largest market share in 2023. Predictive analytics can automate hospital administrative processes, predict staffing needs, and control hospital drug and supply costs, leveraging the performance of hospitals and other healthcare providers.
• Payers segment is expected to grow significantly over the forecast period. Rising medical costs have heightened the pressure on health plans to manage financial risk while maintaining quality care.
• North America healthcare predictive analytics market dominated with the largest revenue share of 48.4% in 2023. Increasing demand for personalized medicine, rising focus on improving patient care, and robust healthcare infrastructure are some of the factors driving market growth.
• Healthcare predictive analytics market in Asia Pacific is anticipated to grow at the fastest CAGR of 26.9% from 2024 to 2030 due to increasing disposable income, rising healthcare expenditure, and technological advancements such as the integration of artificial intelligence in healthcare.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Application Segment
  • 1.2.2. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Healthcare Predictive Analytics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising Adoption of Electronic Health Records (EHRs) and Big Data
    • 3.2.1.2. Advancements in artificial intelligence (AI) and machine learning technologies
    • 3.2.1.3. Rising prevalence of chronic diseases and growing focus on personalized medicine
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Ethical concerns related to data privacy
• 3.3. Healthcare Predictive Analytics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Emerging Technologies Trends
  • 3.3.5. Case Study & Insights
    • 3.3.5.1. Use Cases
    • 3.3.5.2. Related Survey
  • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Healthcare Predictive Analytics Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Healthcare Predictive Analytics Market Application Movement Analysis
• 4.3. Global Healthcare Predictive Analytics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 4.4. Operations Management
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Demand Forecasting
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Workforce Planning and Scheduling
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Inpatient Scheduling
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Outpatient Scheduling
    • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Financial
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Revenue Cycle Management
    • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Fraud Detection
    • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Other Financial Applications
    • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Population Health
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.2. Population Risk Management
    • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.3. Patient Engagement
    • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.4. Population Therapy Management
    • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.5. Other Applications
    • 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Clinical
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7.2. Quality Benchmarking
    • 4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7.3. Patient Care Enhancement
    • 4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7.4. Clinical Outcome Analysis and Management
    • 4.7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Healthcare Predictive Analytics Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Healthcare Predictive Analytics Market End Use Movement Analysis
• 5.3. Global Healthcare Predictive Analytics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Payers
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Providers
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Life Science Industry
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Healthcare Predictive Analytics Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework/ reimbursement structure
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Canada
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Mexico
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Germany
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. France
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Italy
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. Spain
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Norway
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.7. Sweden
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework/ reimbursement structure
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. China
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. India
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Australia
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework/ reimbursement structure
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Thailand
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework/ reimbursement structure
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Argentina
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. South Africa
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework/ reimbursement structure
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework/ reimbursement structure
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.3. UAE
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework/ reimbursement structure
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.4. Kuwait
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework/ reimbursement structure
    • 6.8.4.3. Competitive scenario
    • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2023
• 7.4. Company Profiles/Listing
  • 7.4.1. IBM
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Verisk Analytics, Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. McKesson Corp.
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. SAS
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Oracle
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Allscripts (now Veradigm)
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Optum, Inc.
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. MedeAnalytics, Inc.
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. INFRAGISTICS
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Cloudera
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. Health Catalyst
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. IQVIA Inc
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Inovalon
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. OSP
    • 7.4.14.1. Company overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives